Point6 Bio
PrivateLast Round
Seed
May 1, 2023
Total Funding Raised
$1.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Point6 Bio is a biotechnology company that develops an AI-driven computational biology platform for the early diagnosis and treatment of neurodevelopmental and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Point6 Bio Comparables
Compare Point6 Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iDiagnostix Ltd | 84% | |
| Andia Health | 83% | |
| Cell-El Therapeutics Ltd. | 83% |
Point6 Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 1, 2023 | ||||
| Grant | Mar 21, 2023 |
Point6 Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VLX Ventures | Seed |
| Endless Frontier Labs | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 104% MoM.
- Jun 6, 2024
Grew 43% QoQ, from 7 to 10 employees.
Point6 Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Point6 Bio's valuation, stock price, and market status.
Is Point6 Bio a public or private company?
Point6 Bio is a private company.
What is the current stock price of Point6 Bio?
Point6 Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Point6 Bio worth (valuation)?
Valuation information for Point6 Bio is not publicly available.
Can I buy Point6 Bio stock?
Point6 Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Point6 Bio's last funding round?
Point6 Bio's most recent funding round was Seed on May 1, 2023.
Who are the main investors in Point6 Bio?
Key investors in Point6 Bio include VLX Ventures, Endless Frontier Labs.
Will Point6 Bio IPO soon?
No public IPO plans have been announced for Point6 Bio.
How can I track Point6 Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Point6 Bio's secondary market activity and sign up for updates.